Parabilis Medicines, Inc. SEC filings PBLS
Parabilis Medicines, Inc. has 63 filings in SEC EDGAR's recent list, going back to Nov 13, 2015. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 5, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 25, 2026 | Aug 22, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Jun 11, 2026 | Jun 9, 2026 |
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| 424B4 | Prospectus | Jun 10, 2026 | — |
| FWP | Free writing prospectus | Jun 10, 2026 | — |
| EFFECT | Filing | Jun 9, 2026 | — |
| S-1MEF | Filing | Jun 9, 2026 | — |
| CERT | Filing | Jun 9, 2026 | — |
| S-1/A | Amended registration statement | Jun 9, 2026 | — |
| 8-A12B | Filing | Jun 5, 2026 | — |
| S-1/A | Amended registration statement | Jun 4, 2026 | — |
| S-1/A | Amended registration statement | May 27, 2026 | — |
| S-1 | Registration statement | May 19, 2026 | — |
| DRS | Filing | Apr 2, 2026 | — |
| D | Filing | Dec 2, 2022 | — |
| D | Filing | Jan 5, 2021 | — |
| D/A | Filing | May 16, 2018 | — |
| D | Filing | Feb 14, 2018 | — |
| D/A | Filing | Aug 22, 2017 | — |
| D | Filing | Jun 7, 2016 | — |
| D | Filing | Nov 13, 2015 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBLS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1657677
- Former names
- FOG PHARMACEUTICALS, INC. (until Dec 2, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.